Upcoming Events
Log In
Pricing
Free Trial

Wk 2, Case 2 - Review

HIDE
PrevNext

0:00

65-year-old presented from outside facility,

0:03

recently biopsied left axillary mass, and no

0:06

demonstrating grade 3 invasive ductal carcinoma,

0:08

and this is for evaluating extended disease.

0:12

Of course, in this case, if we have

0:13

something with biopsy-proven axillary

0:16

whatever, either node or mass.

0:19

Oops.

0:19

Oh, sorry about that.

0:21

Oops.

0:22

That's not going to help.

0:23

Um, let me pull that up again.

0:26

Um, so if you do have something that

0:28

is, uh, an axillary node, you do

0:33

want to, of course, go looking for that,

0:35

um, for something in the breast, right?

0:37

And the typical pathway, of course,

0:39

is to do a mammogram first, right?

0:40

If you can see something by mammogram

0:42

and you can do an ultrasound and biopsy

0:43

that way, that would be one approach.

0:45

That'd be great.

0:46

Um, but of course, if that imaging is negative,

0:49

then the recommendation typically would

0:52

be to go onto an MRI exam to try to

0:55

discover, um, you know, smaller areas that

0:58

were mammographically or sonographically cold.

1:02

Um, so let's see.

1:03

So in this case, this was left side.

1:06

So, you know, already in our MRI here

1:09

again, we can see this large, um,

1:11

axillary mass or large axillary node.

1:14

Um, you know, maybe something here as

1:16

well, and we'll have to determine whether

1:18

that's just, you know, benign-looking,

1:20

um, intramammary node or something else.

1:23

Um, and then if we rotate this just a

1:25

little bit to get this vessel out of the

1:26

way, we can see two little small areas

1:28

here in the left breast, which we'd want

1:32

to make sure that we interrogate further.

1:35

So let me pull down our seal again here.

1:42

So let's first go look up that,

1:44

uh, nodal area or direction.

1:48

Okay.

1:48

So that's sort of coming into view here.

1:50

It looks like a large, um, you know, level

1:52

one, uh, or, you know, maybe one slash two,

1:56

uh, node or conglomeration of nodes, um, uh,

2:01

any way to describe that is probably okay.

2:03

It looks like we're getting relatively

2:05

high here up into maybe level two as well.

2:07

Some of them look like they.

2:09

You know, either have potentially

2:11

some necrosis in there.

2:13

Um, but the other, um, important piece on

2:17

this case, um, is that we want to evaluate,

2:20

um, whether this thing is attached to the

2:23

pectoralis muscles or not, and that can be

2:25

difficult to do, especially in an area like

2:27

right here, where, um, there's, there's

2:30

you know, maybe not a definite fat plane.

2:33

Um, I think in this case, for the most

2:36

part, there is, there does maintain

2:38

a fat plane between the pectoralis

2:40

musculature and the nodal conglomeration.

2:43

Um, it can sometimes be helpful to

2:45

look at the sagittal, see if I can go

2:48

the right way here, um, to do that.

2:51

So, whoops, uh, so in this case,

2:53

here, we see a nice fat plane here

2:55

between, uh, pectoralis major.

2:58

Posteriorly, it's a little bit more difficult

3:00

to see, but, you know, maybe something in here.

3:03

It's a little hard to see where pec minor

3:05

is in this, in this satchel, but it is

3:10

something that you'd want to mention and, you

3:12

know, it's, it's not like it's gonna change

3:14

anything too much, but I think your surgical

3:17

providers would, um, really want to know

3:20

that information, whether they're going to be

3:22

having to dig into the pec a little bit, uh,

3:24

to get this thing out or whether it's something

3:25

that might come out a little more easily.

3:28

Um, so back to the breast, um, we do see these

3:33

tiny little irregular, uh, irregular masses

3:38

right next to each other, um, which are likely

3:40

the cause of, um, this nodal englaboration.

3:43

Of course, we'd want to verify that and, um,

3:45

Um, biopsy these things, so we could either

3:48

go to targeted ultrasound, look for it in

3:51

the breast, uh, that way, um, and if not seen

3:53

there, then move on to MRI-guided biopsy

3:56

to verify that that was truly the case or not.

4:00

Um, this node is difficult, um, you know,

4:03

there's perhaps a little fatty hilum there

4:05

that we can see if you look closely, probably

4:06

doesn't project real well on our shared screen,

4:09

but, um, But you would want to try to kind of

4:13

look like that, look at that a little closer.

4:15

You could also do an ultrasound there if

4:17

you wanted to get your best attempt at

4:19

imaging that and really look at the, uh,

4:22

the cortex that, uh, that would be a very

4:24

reasonable, uh, reasonable approach too.

4:26

Um, of course, if you are wondering about

4:29

that and you think that these masses look

4:30

pretty suspicious, which they do, um,

4:33

you know, whether that, um, node

4:35

is involved or not is a little bit, um,

4:38

it's not as important to figure that out.

4:40

If you prove there's something in the breast

4:42

and you already know that there's metastatic

4:44

axillary disease, then, you know, if there's

4:46

a kind of like an in-transit node, then

4:48

that's a little bit less important unless,

4:50

unless your surgical providers are going to

4:51

try to, you know, remove each of those things

4:54

separately, but that would be a bit difficult.

4:56

This was a case from my institution, and

4:58

I think it was a little bit surprising

5:00

to think that these tiny little things or

5:02

thing could cause that, I know, but that

5:04

was exactly how this patient presented.

5:07

And those were biopsy-proven.

5:10

Um, could I please ask about the

5:12

you did mention about the um, How

5:16

to interpret chest wall invasion?

5:18

Um, um, in this case, yes, it

5:22

did show a bit of a fat plane.

5:23

Is there something like, uh, this

5:26

much contact or these many centimeters

5:29

of contact that would increase the

5:30

chances of a possible invasion?

5:32

Or do we just have to go by whether the

5:34

enhancement is extending into that, um,

5:38

That either the chest wall or the pec.

5:40

Yeah.

5:40

Yeah.

5:41

I don't know of anything that

5:43

describes like, you know, how much

5:46

kind of potential contact there would

5:48

raise your risk of actual invasion.

5:51

Interesting idea, though.

5:53

So I would say that what most people do

5:55

is look at trying to identify, you know,

5:59

that fat plane between, excuse me, um,

6:03

the mass and the pectoralis or chest wall,

6:06

either way, it's sort of the same idea.

6:08

And in my mind, I put it into

6:09

three categories where either it's...

6:12

There's no evidence of invasion.

6:14

So like in this case, or in this image

6:16

here, right, we have a very nice fat plane.

6:18

You could say, yep, no evidence of invasion.

6:20

It's close by, but whatever, no invasion.

6:23

One, uh, the next level for

6:25

me is sort of, it abuts.

6:27

And then you could say, well, it possibly

6:29

invades or probably doesn't invade.

6:31

Um, if you think that it just happens to be that

6:33

the two areas are coming pretty close together.

6:36

Um, and then the other one is

6:39

definite invasion, right?

6:40

You can see that abnormal enhancement

6:42

within the muscle fibers in some way.

6:44

Um, then you can say, yes, um, there's this,

6:47

you know, nodal mass level one nodal mass that looks

6:50

like, or that has abnormal enhancement within

6:52

the musculature compatible with, you know,

6:54

pectoralis invasion or something like that.

6:56

Um, that's kind of how

6:59

I break it apart in my mind.

7:00

We do occasionally see cases where

7:01

that invasion or abutting, um, the

7:05

musculature can be quite focal.

7:07

Um, so, uh, I think it is worth mentioning and

7:12

not, um, even if the rest of it is definitely

7:16

not invading, it would be good to say, oh,

7:18

it's, you know, focally abuts it here at this

7:21

location or focally invades the muscle at

7:23

this, at this site, and that would be useful.

7:27

Were you able to see those

7:28

little masses on ultrasound?

7:31

Yes, I believe we were.

7:33

I believe we were.

7:34

It's been a while.

7:36

Thank you.

7:39

Yeah, in this case, you know I mentioned last

7:41

week I think camera if you're on or not but

7:43

you know the couple of couple sort of basic

7:45

sort of criteria that we use for determining

7:48

whether we should do targeted ultrasound, or

7:52

not, would be you're more likely to see it.

7:55

If, uh, it is a mass you're describing

7:57

rather than non-mass enhancement,

7:59

and usually 10, 10 millimeters.

8:00

So this would be a little bit less than

8:01

that, but, um, but given its location, you

8:04

know, relatively superficial, um, I think it

8:07

would be a good chance of, of seeing this on

8:08

ultrasound and would probably recommend that.

8:11

Of course, this is our particular institution.

8:14

We do have, um, pretty good availability

8:16

for doing, um, MRI guided biopsies.

8:19

Uh, and so we do leave it up to our interpreting

8:22

radiologist to determine whether they want

8:24

to go just straight to, uh, biopsy or not,

8:27

based on their assessment of how likely it

8:29

is that they're going to see it on ultrasound.

8:32

That may be very different

8:33

at other institutions.

Report

HISTORY: 65-year-old female presenting from an outside facility with recently biopsied left axillary mass and node demonstrating grade 3 invasive ductal carcinoma (ER+, PR-, HER2+). Evaluate extent of disease.

Summary of prior imaging:

Mammography: Incompletely visualized left axillary mass with circumscribed margins measuring at least 38 mm.

Ultrasound: Targeted ultrasound of the left axilla demonstrates a markedly abnormal lymph node with cortical thickness of 12 mm, but a preserved fatty hilum. There is an adjacent oval mass with indistinct margins measuring up to 28 mm.

Breast MRI: NA

FINDINGS

Quality control issues: ☒None ☐Poor/lack contrast bolus ☐Poor fat suppression
☐Susceptibility ☐Movement ☐Other

Background Parenchymal Enhancement: Minimal

Amount of Fibroglandular Tissue: Scattered fibroglandular tissue

LEFT BREAST

Narrative: At 2:00 anterior depth, approximately 6 cm from the nipple, there is an irregular mass with irregular margins which measures 1.1 cm (AP). There is homogeneous internal enhancement. Worst curve kinetics are initial phase rapid and delayed phase plateau. There is an additional mass measuring 0.6 cm (CC) which is 0.6 cm inferior and lateral to the mass described above. In total the two masses span a distance of 2.2 cm.

There are markedly large abnormal level I and II conglomerate lymph nodes. Two foci of susceptibility artifact are identified within this nodal conglomerate compatible with biopsy clips. The nodal conglomerate abuts and partially surrounds the pectoralis minor muscle, but there is no evidence of pectoral invasion. Superiorly, the nodal conglomerate abuts the axillary veinand abnormal infraclavicular nodes are demonstrated.

Left breast lesion 1
Lesion type: Mass
1.1 cm. Upper outer Quadrant. 2:00 Radian. 6 cm from the nipple

Mass/post-surgical change: Shape:Irregular. Margins:Not circumscribed-irregular.

Enhancement: Homogenous. Kinetics: upslope -Fast, delayed-Plateau

BI-RADS:4: Suspicious abnormality – Biopsy should be considered

Left breast lesion 2
Lesion type: Mass
0.6 cm. Upper outer Quadrant. 2:00 Radian. 5 cm from the nipple

Mass/post-surgical change: Shape:Irregular. Margins:Not circumscribed-irregular.

Enhancement: Homogenous. Kinetics: upslope -Fast, delayed-Plateau

BI-RADS:4: Suspicious abnormality – Biopsy should be considered

Associated findings LEFT breast: ☐Nipple retraction, ☐Nipple involvement, ☐Skin
retraction, ☐Skin thickening, ☐Skin invasion-direct, ☐Skin invasion-inflammatory,
☐Pectoral muscle invasion, ☐Chest wall invasion, ☐ Architectural distortion

Non-enhancing findings LEFT breast: ☐High ductal signal pre contrast T1, ☐Cyst(s), ☐Hematoma/seroma, ☐Post therapy skin/trabecular thickening, ☐Non-enhancing mass, ☐Architectural distortion, ☒Signal void from clips

Fat containing lesions LEFT: ☐Fat necrosis, ☐Hamartoma, ☐Post-operative
seroma/hematoma with fat

Lymph nodes LEFT: ☐Normal axillary, ☒Abnormal axillary: Markedly enlarged abnormal level I and II lymph nodes, ☐ Abnormal internal mammary

RIGHT BREAST

Narrative: Negative. No suspicious enhancement or lymphadenopathy.

Associated findings RIGHT breast: ☐Nipple retraction, ☐Nipple involvement, ☐Skin retraction, ☐Skin thickening, ☐Skin invasion-direct, ☐Skin invasion-inflammatory, ☐Pectoral muscle invasion, ☐Chest wall invasion, ☐ Architectural distortion

Non-enhancing findings RIGHT breast: ☐High ductal signal pre contrast T1, ☐Cyst(s), ☐Hematoma/seroma, ☐Post therapy skin/trabecular thickening, ☐Non-enhancing mass, ☐Architectural distortion, ☐Signal void from clips

Fat containing lesions RIGHT: ☐Fat necrosis, ☐Hamartoma, ☐Post-operative
seroma/hematoma with fat

Lymph nodes RIGHT: ☒Normal axillary, ☐Abnormal axillary: description, ☐ Abnormal internal mammary

Extramammary findings: None

SUMMARY:
1. Two adjacent masses in the left breast at 2:00 anterior depth, which measure up to 2.2 cm on MRI in total. BI-RADS:4: Suspicious abnormality – Biopsy should be considered

2. Markedly abnormal level I and II axillary nodal conglomeration, previously biopsied demonstrating malignancy. Superiorly, there are abnormal infraclavicular lymph nodes and the nodal conglomerate appears to abut the axillary vein. The nodal conglomerate abuts but does invade the pectoralis minor muscle.

RECOMMENDATIONS: Image-guided biopsy of one of the adjacent masses in the left breast
at 2:00.

Case Discussion

Faculty

Petra J Lewis, MBBS

Professor of Radiology and OBGYN

Dartmouth-Hitchcock Medical Center & Geisel School of Medicine at Dartmouth

Sheryl G. Jordan, MD

Professor, Department of Radiology

University of North Carolina School of Medicine

Ryan W. Woods, MD, MPH

Assistant Professor of Radiology

University of Wisconsin School of Medicine and Public Health

Tags

Women's Health

MRI

Breast

© 2024 Medality. All Rights Reserved.

Contact UsTerms of UsePrivacy Policy